1. CentyMed Pharmaceutical Inc., founded by the company team in the United States, has complete equipment and venues.

2. The main members of the team include specialists with high-end core technology in antibody pharmacology, tumor immunology and experimental oncology, with more than 10 years of experience in antibody R&D; specialists with experience in establishing multiple companies and specialists with more than 10 years of experience in stable cell line construction, antibody production and purification.

3. All the mid- and late-stage antibody drug research and development will be undertaken in Zhejiang Shimai Pharmaceutical Co.,Ltd, including antibody production and purification, animal experiments, IND declaration and clinical experiments.

4. The senior management and technical team will focus on the development of domestic companies. Basis on the strong research and development platform, they will cooperate with excellent drug R&D enterprises, universities and scientific research institutions in China and the United States to give full play to the advantages of all parties in order to expand the company's competitiveness as soon as possible.